AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Value of Annual Pap Smears Questioned.

OB GYN News

| February 15, 2001 | ZOLER, MITCHEL L. | COPYRIGHT 2001 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

Many postmenopausal U.S. women are needlessly screened with an annual cervical smear.

When postmenopausal women have a cervical smear taken within 2 years of a previously normal smear, the problem is not just that the second smear wastes time and money. It also risks a false-positive result that leads to needless anxiety, follow-up tests, and cost.

"Postmenopausal women and their physicians should be aware that the risks of a false-positive finding from cervical smear screening are greater than the potential benefits" when the smear is done less than 2 years after a normal smear, Dr. George F. Sawaya, an ob.gyn, at the University of California, San Francisco, said in an interview.

Dr. Sawaya and his associates came to this conclusion after reviewing the smears and subsequent outcomes of 2,561 postmenopausal women who participated in the Heart and Estrogen/Progestin Replacement Study (HERS) (Ann. Intern. Med., 133[12]:942-50, 2000).

"Most U.S. gynecologists still recommend annual screening regardless of age or past Pap history," Dr. Evan R. Myers, an ob.gyn. at Duke University in Durham, N.C., told this newspaper.

Annual Pap smears remain the rule for postmenopausal women in the United States. Data collected by the Centers for Disease Control and Prevention in an annual telephone survey, the Behavioral Risk Factor Surveillance System, showed that in 1999, 68% of women aged 50-59 reported having a cervical smear taken within the past year. In addition, 63% of women aged 60-64 and 52% of women aged 65 or older also reported having a Pap smear within the past year. Data for 1997 and 1998 show that at least 50% of women in each of these age categories had a Pap smear within the last year, suggesting that many were undergoing the procedure annually.

In HERS, annual cervical smears were taken as part of the study protocol. Dr. Sawaya's analysis focused on the 2,561 women who had a normal smear taken at ...

Related articles from newspapers, magazines, journals, and more
Annual Pap Smears Unnecessary In Most Postmenopausal Women.(Brief Article)
Magazine article from: Family Practice News ZOLER, MITCHEL L. March 15, 2001 700+ words
...screened with an annual cervical smear. When postmenopausal women have a cervical smear taken within 2 years...tests, and cost. "Postmenopausal women and their physicians...positive finding from cervical smear screening are greater...
Health issues in postmenopausal women who drink.
Magazine article from: Alcohol Research & Health Register, Thomas C. Cline, J. Mark Shively, Carol A. December 22, 2002 700+ words
...these three diseases in postmenopausal women. The authors stress...potential health effects in postmenopausal women should be interpreted...and well. being of postmenopausal women through the direct...
FDA Approves Lilly's Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The...
Press release article from: PR Newswire September 14, 2007 700+ words
...reduce invasive breast cancer risk in postmenopausal women with osteoporosis INDIANAPOLIS...breast cancer in two populations: postmenopausal women with osteoporosis and postmenopausal women at high risk for invasive breast...
FDA Advisory Committee Recommends Approval of EVISTA for the Reduction of Risk...
Press release article from: PR Newswire July 24, 2007 700+ words
...provide an important option for postmenopausal women at increased risk for breast cancer...cancer risk in two populations: postmenopausal women with osteoporosis and postmenopausal women at high risk for breast cancer...
ARZOXIFENE LIFTS BMD IN POSTMENOPAUSAL WOMEN BETTER THAN EVISTA.
News wire article from: AsiaPulse News March 24, 2009 700+ words
...raloxifene HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis ATHENS, Mar 23...Turnover Markers versus Raloxifene in Postmenopausal Women with Osteoporosis Eli Lilly and...and treatment of osteoporosis in postmenopausal women and the reduction of risk of invasive...
Novartis Launches Z-FAST: A Study Evaluating Femara(R) and Zometa(R) in...
Press release article from: PR Newswire December 10, 2002 700+ words
...treatment-related bone loss in postmenopausal women with early breast cancer Novartis...associated with cancer treatment in postmenopausal women with early breast cancer. The Novartis...benefit from this information -- postmenopausal women receiving aromatase inhibitor therapy...
Special Feature: Unilocular Ovarian Cysts in Postmenopausal Women: Surgery vs...
Magazine article from: OB/GYN Clinical Alert January 1, 2004 700+ words
...Feature Unilocular Ovarian Cysts in Postmenopausal Women: Surgery vs Expectant Management...and required surgical resection. Postmenopausal women werent supposed to have ovarian...evidence that the vast majority of postmenopausal women with unilocular ovarian cysts up...
Eli Lilly and Company Submits New Drug Application for EVISTA for Reduction of...
Press release article from: PR Newswire December 7, 2006 700+ words
...risk of invasive breast cancer in postmenopausal women with osteoporosis and postmenopausal women at high risk for breast cancer...and prevention of osteoporosis in postmenopausal women. "If approved, EVISTA would be...
For more facts and information, see all results

Source: HighBeam Research, Value of Annual Pap Smears Questioned.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA